CC

Casdin Capital Portfolio holdings

AUM $1.1B
This Quarter Return
+23.9%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$409M
AUM Growth
+$409M
Cap. Flow
+$28.6M
Cap. Flow %
6.98%
Top 10 Hldgs %
66%
Holding
28
New
2
Increased
13
Reduced
1
Closed
2

Top Buys

1
FATE icon
Fate Therapeutics
FATE
$12.5M
2
GBT
Global Blood Therapeutics, Inc.
GBT
$5.31M
3
VYGR icon
Voyager Therapeutics
VYGR
$5.31M
4
GNMK
GenMark Diagnostics, Inc
GNMK
$5.13M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$4.78M

Top Sells

1
KITE
Kite Pharma, Inc.
KITE
$19.1M
2
TSRO
TESARO, Inc.
TSRO
$4.97M
3
OVID icon
Ovid Therapeutics
OVID
$469K

Sector Composition

1 Healthcare 93.42%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SAGE
1
DELISTED
Sage Therapeutics
SAGE
$41.2M 10.03% 250,000 +10,000 +4% +$1.65M
FMI
2
DELISTED
Foundation Medicine, Inc.
FMI
$35.5M 8.64% 520,000 +40,000 +8% +$2.73M
LOXO
3
DELISTED
Loxo Oncology, Inc
LOXO
$30.3M 7.38% 360,000 – –
BPMC
4
DELISTED
Blueprint Medicines
BPMC
$26.2M 6.39% 348,000 +50,000 +17% +$3.77M
BLUE
5
DELISTED
bluebird bio
BLUE
$25.8M 6.29% 145,000 – –
ALNY icon
6
Alnylam Pharmaceuticals
ALNY
$58.5B
$25.4M 6.19% 200,000 – –
MYOK
7
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$23.6M 5.74% 560,000 – –
SGMO icon
8
Sangamo Therapeutics
SGMO
$157M
$23M 5.59% 1,400,000 – –
GBT
9
DELISTED
Global Blood Therapeutics, Inc.
GBT
$20.3M 4.94% 515,000 +135,000 +36% +$5.31M
VYGR icon
10
Voyager Therapeutics
VYGR
$186M
$18.8M 4.59% 1,135,000 +320,000 +39% +$5.31M
AGIO icon
11
Agios Pharmaceuticals
AGIO
$2.19B
$16.9M 4.11% 295,000 +40,000 +16% +$2.29M
FATE icon
12
Fate Therapeutics
FATE
$120M
$15.9M 3.87% 2,600,000 +2,050,000 +373% +$12.5M
ONCE
13
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$15.6M 3.79% 302,474 +93,000 +44% +$4.78M
CDXS icon
14
Codexis
CDXS
$246M
$13.4M 3.25% 1,600,000 +125,000 +8% +$1.04M
EVH icon
15
Evolent Health
EVH
$1.12B
$13.3M 3.23% 1,077,500 +282,500 +36% +$3.47M
BOLD
16
DELISTED
Audentes Therapeutics, Inc
BOLD
$12.5M 3.04% 400,000 – –
GNMK
17
DELISTED
GenMark Diagnostics, Inc
GNMK
$11.4M 2.77% 2,730,000 +1,230,000 +82% +$5.13M
ILMN icon
18
Illumina
ILMN
$15.8B
$9.61M 2.34% 44,000 – –
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
$8.67M 2.11% 127,500 – –
JNCE
20
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$6.06M 1.47% 475,000 +75,175 +19% +$958K
EDIT icon
21
Editas Medicine
EDIT
$231M
$4.1M 1% 133,333 – –
CTMX icon
22
CytomX Therapeutics
CTMX
$336M
$3.75M 0.91% 177,500 – –
SYRS
23
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.67M 0.65% 274,074 +17,859 +7% +$174K
GILD icon
24
Gilead Sciences
GILD
$140B
$2.15M 0.52% +30,000 New +$2.15M
ONC
25
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$1.76M 0.43% +18,000 New +$1.76M
1
2